Title
Prospective observational data informs understanding and future management of Lynch syndrome: insights from the Prospective Lynch Syndrome Database (PLSD)
Date Issued
01 January 2021
Access level
open access
Resource Type
review
Author(s)
Oslo University Hospital
Publisher(s)
Springer Science and Business Media B.V.
Abstract
The Prospective Lynch Syndrome Database (PLSD) has been developed as an international, multicentre, prospective, observational study that aims to provide age and organ-specific cancer risks according to gene and gender, estimates of survival after cancer and information on the effects of interventions. Recent reports from PLSD provided improved estimates of cancer risks and survival and showed that different time intervals between surveillance colonoscopies did not affect the incidence, stage or prognosis of colorectal cancer. The PLSD reports suggest that current management guidelines for Lynch syndrome should be revised in light of the different gene and gender-specific cancer risks and the good prognosis for the most commonly associated cancers. In this review, we describe the discrepancies between the current management guidelines for Lynch Syndrome and the most recent prospective observational studies, indicating the areas of further research.
Start page
35
End page
39
Volume
20
Issue
1
Language
English
OCDE Knowledge area
Oncología
Subjects
Scopus EID
2-s2.0-85086017768
PubMed ID
Source
Familial Cancer
Resource of which it is part
Familial Cancer
ISSN of the container
13899600
Source funding
Suomen Lääketieteen Säätiö
Sponsor(s)
Open access funding provided by University of Helsinki including Helsinki University Central Hospital. TTS was supported by the Emil Aaltonen Foundation, the Finnish Medical Foundation and the Sigrid Juselius Foundation. TTS is a co-owner of Healthfund Finland Oy.
Open access funding provided by University of Helsinki including Helsinki University Central Hospital. TTS was supported by the Emil Aaltonen Foundation, the Finnish Medical Foundation and the Sigrid Juselius Foundation. TTS is a co-owner of Healthfund Finland Oy.
Sources of information:
Directorio de Producción Científica
Scopus